123 related articles for article (PubMed ID: 7680639)
1. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.
Lutty GA; Merges C; Threlkeld AB; Crone S; McLeod DS
Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):477-87. PubMed ID: 7680639
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye.
Pfeffer BA; Flanders KC; Guérin CJ; Danielpour D; Anderson DH
Exp Eye Res; 1994 Sep; 59(3):323-33. PubMed ID: 7821377
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye.
Pasquale LR; Dorman-Pease ME; Lutty GA; Quigley HA; Jampel HD
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):23-30. PubMed ID: 8425829
[TBL] [Abstract][Full Text] [Related]
4. Distribution of transforming growth factor-beta isoforms in the mammalian retina.
Anderson DH; Guerin CJ; Hageman GS; Pfeffer BA; Flanders KC
J Neurosci Res; 1995 Sep; 42(1):63-79. PubMed ID: 8531227
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer.
Williams AO; Flanders KC; Saffiotti U
Am J Pathol; 1993 Jun; 142(6):1831-40. PubMed ID: 8389528
[TBL] [Abstract][Full Text] [Related]
6. Histochemical localization of transforming growth factor-beta 1 in developing rat molars using antibodies to different epitopes.
D'Souza RN; Happonen RP; Flanders KC; Butler WT
J Biol Buccale; 1990 Dec; 18(4):299-306. PubMed ID: 1710211
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of transforming growth factor-beta 1, -beta 2, and -beta 3 latency-associated peptide in human cornea.
Nishida K; Kinoshita S; Yokoi N; Kaneda M; Hashimoto K; Yamamoto S
Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3289-94. PubMed ID: 8045718
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing.
Kane CJ; Hebda PA; Mansbridge JN; Hanawalt PC
J Cell Physiol; 1991 Jul; 148(1):157-73. PubMed ID: 1907288
[TBL] [Abstract][Full Text] [Related]
9. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues.
Karakousis PC; John SK; Behling KC; Surace EM; Smith JE; Hendrickson A; Tang WX; Bennett J; Milam AH
Mol Vis; 2001 Jun; 7():154-63. PubMed ID: 11438800
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta in experimentally detached retina and periretinal membranes.
Guérin CJ; Hu L; Scicli G; Scicli AG
Exp Eye Res; 2001 Dec; 73(6):753-64. PubMed ID: 11846507
[TBL] [Abstract][Full Text] [Related]
12. Localization of cannabinoid CB1 receptors in the human anterior eye and retina.
Straiker AJ; Maguire G; Mackie K; Lindsey J
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2442-8. PubMed ID: 10476817
[TBL] [Abstract][Full Text] [Related]
13. Retinal control on the axial length mediated by transforming growth factor-beta in chick eye.
Honda S; Fujii S; Sekiya Y; Yamamoto M
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2519-26. PubMed ID: 8933768
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of transforming growth factor-beta after panretinal photocoagulation.
Ishida K; Yoshimura N; Yoshida M; Honda Y
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):801-7. PubMed ID: 9538888
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system.
Chaudhry A; Oberg K; Gobl A; Heldin CH; Funa K
Anticancer Res; 1994; 14(5B):2085-91. PubMed ID: 7840504
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 2 and TGF-beta 3 immunoreactivity within the ciliary epithelium [corrected].
Peress NS; Perillo E
Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):453-7. PubMed ID: 8112993
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptor expression in human cornea.
Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1922-8. PubMed ID: 9331255
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
[TBL] [Abstract][Full Text] [Related]
19. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue.
Barcellos-Hoff MH; Ehrhart EJ; Kalia M; Jirtle R; Flanders K; Tsang ML
Am J Pathol; 1995 Nov; 147(5):1228-37. PubMed ID: 7485387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
